Item Type | Name |
Concept
|
Acute Disease
|
Concept
|
Acid Phosphatase
|
Concept
|
Aged, 80 and over
|
Concept
|
Alkaline Phosphatase
|
Concept
|
Anemia, Refractory, with Excess of Blasts
|
Concept
|
Adolescent
|
Concept
|
Aged
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Adult
|
Concept
|
Anemia, Sideroblastic
|
Concept
|
Anemia, Refractory
|
Concept
|
Chromosome Banding
|
Concept
|
Chromosomes, Human, Pair 11
|
Concept
|
Chromosomes, Human, Pair 2
|
Concept
|
Chromosomes, Human, Pair 6
|
Concept
|
Antitubercular Agents
|
Concept
|
Analysis of Variance
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Chromosomes, Human, Pair 8
|
Concept
|
Cyclosporins
|
Concept
|
B-Lymphocytes
|
Concept
|
Base Sequence
|
Concept
|
Benzamides
|
Concept
|
Basophils
|
Concept
|
Azacitidine
|
Concept
|
Binding Sites
|
Concept
|
Blast Crisis
|
Concept
|
Biopsy, Needle
|
Concept
|
Bone Marrow Examination
|
Concept
|
Child
|
Concept
|
Chromosomes, Human, Pair 21
|
Concept
|
Chromosomes, Human, Pair 3
|
Concept
|
Chromosomes, Human, 4-5
|
Concept
|
Cat-Scratch Disease
|
Concept
|
Chromosomes, Human, Pair 12
|
Concept
|
Chromosomes, Human, Pair 14
|
Concept
|
Chromosomes, Human, 6-12 and X
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Chromosomes, Human, Pair 13
|
Concept
|
Chromosomes, Human, Pair 22
|
Concept
|
Burkitt Lymphoma
|
Concept
|
Chromosomes, Human, Pair 5
|
Concept
|
Chromosomes, Human, Pair 7
|
Concept
|
Chromosomes, Human, 13-15
|
Concept
|
Cisplatin
|
Concept
|
Chromosomes, Human, 16-18
|
Concept
|
Chromosomes, Human, 21-22 and Y
|
Concept
|
Hematocrit
|
Concept
|
Hemoglobins
|
Concept
|
Colony-Stimulating Factors
|
Concept
|
Drug Synergism
|
Concept
|
Interleukin-2
|
Concept
|
Leukemia, Erythroblastic, Acute
|
Concept
|
Down Syndrome
|
Concept
|
Child, Preschool
|
Concept
|
Cyclophosphamide
|
Concept
|
Daunorubicin
|
Concept
|
Glucocorticoids
|
Concept
|
Leukemia, Lymphoid
|
Concept
|
Immunologic Factors
|
Concept
|
Chromosomes, Human, Pair 17
|
Concept
|
Chromosomes, Human, Pair 9
|
Concept
|
Chromosomes, Human, 19-20
|
Concept
|
Erythropoietin
|
Concept
|
Etoposide
|
Concept
|
Cytarabine
|
Concept
|
Diphtheria Toxin
|
Concept
|
Drug Resistance
|
Concept
|
Interferons
|
Concept
|
Neoplasms, Multiple Primary
|
Concept
|
Histocytochemistry
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Immune Sera
|
Concept
|
Lions
|
Concept
|
Immunologic Capping
|
Concept
|
Clinical Enzyme Tests
|
Concept
|
Eosinophils
|
Concept
|
Hypergammaglobulinemia
|
Concept
|
Flow Cytometry
|
Concept
|
Immunoglobulin gamma-Chains
|
Concept
|
Infant
|
Concept
|
Francisella
|
Concept
|
International Cooperation
|
Concept
|
Granulocytes
|
Concept
|
Lymphoproliferative Disorders
|
Concept
|
Macrophages
|
Concept
|
Leukocytes
|
Concept
|
Pilot Projects
|
Concept
|
Lymphopenia
|
Concept
|
Myeloproliferative Disorders
|
Concept
|
Mice, Inbred CBA
|
Concept
|
Immunohistochemistry
|
Concept
|
Organ Size
|
Concept
|
Molecular Sequence Data
|
Concept
|
Neoplastic Cells, Circulating
|
Concept
|
Methotrexate
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Middle Aged
|
Concept
|
Random Allocation
|
Concept
|
Mitoxantrone
|
Concept
|
Myelodysplastic Syndromes
|
Concept
|
Pathology, Clinical
|
Concept
|
Periodic Acid-Schiff Reaction
|
Concept
|
Interleukin-3
|
Concept
|
Neutrophils
|
Concept
|
Phagocytosis
|
Concept
|
Philadelphia Chromosome
|
Concept
|
Liver
|
Concept
|
Lymphatic Diseases
|
Concept
|
Lymphokines
|
Concept
|
Metaphase
|
Concept
|
Phosphorylation
|
Concept
|
Platelet Aggregation
|
Concept
|
Polycythemia Vera
|
Concept
|
Plasma Cells
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Proto-Oncogene Proteins
|
Concept
|
Genetic Markers
|
Concept
|
Hodgkin Disease
|
Concept
|
Immunoglobulin G
|
Concept
|
Immunoenzyme Techniques
|
Concept
|
Remission, Spontaneous
|
Concept
|
Haemophilus
|
Concept
|
RNA-Directed DNA Polymerase
|
Concept
|
Risk Factors
|
Concept
|
RNA, Neoplasm
|
Concept
|
Quinacrine
|
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
Leukemia, B-Cell
|
Concept
|
Snakes
|
Concept
|
Risk
|
Concept
|
Thymidine
|
Concept
|
Histones
|
Concept
|
Humans
|
Concept
|
Leukemia, Radiation-Induced
|
Concept
|
Leukocyte Count
|
Concept
|
Thalidomide
|
Concept
|
Thrombocytosis
|
Concept
|
Immunoglobulin lambda-Chains
|
Concept
|
Interferon Type I
|
Concept
|
Thrombocythemia, Essential
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Concept
|
Leukemia, Myeloid, Accelerated Phase
|
Concept
|
Leukemia, Neutrophilic, Chronic
|
Concept
|
HTLV-I Infections
|
Concept
|
Lymphocytosis
|
Concept
|
Lymphoid Tissue
|
Concept
|
Lymphoma, Follicular
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Oncogene Proteins, Fusion
|
Concept
|
Proportional Hazards Models
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Vidarabine
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Histiocytosis, Sinus
|
Concept
|
Up-Regulation
|
Concept
|
Mice, Inbred DBA
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Pentostatin
|
Concept
|
Lymph Nodes
|
Concept
|
Lymphoma
|
Concept
|
Multiple Myeloma
|
Concept
|
DNA Probes
|
Concept
|
Methylation
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Interferon-alpha
|
Concept
|
Mice, Knockout
|
Concept
|
Disease Progression
|
Concept
|
Antineoplastic Agents, Alkylating
|
Concept
|
Antigens, CD20
|
Concept
|
Angiogenesis Inhibitors
|
Concept
|
BRCA1 Protein
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
Concept
|
Cladribine
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Chromatin Immunoprecipitation
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p16
|
Concept
|
Proto-Oncogene Proteins c-kit
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
Concept
|
Platelet Count
|
Concept
|
Mice
|
Concept
|
Quinacrine Mustard
|
Concept
|
Primary Myelofibrosis
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Sex Factors
|
Concept
|
Spleen
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Zymosan
|
Concept
|
Human T-lymphotropic virus 1
|
Concept
|
Multivariate Analysis
|
Concept
|
Logistic Models
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
CD4-CD8 Ratio
|
Concept
|
Blotting, Southern
|
Concept
|
Blotting, Northern
|
Concept
|
Abnormal Karyotype
|
Concept
|
Platelet Transfusion
|
Concept
|
Survival Rate
|
Concept
|
Fusion Proteins, bcr-abl
|
Concept
|
Lymphocyte Subsets
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
Concept
|
Patient Selection
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
Leukemic Infiltration
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Drug Resistance, Multiple
|
Concept
|
Cell Lineage
|
Concept
|
Heterogeneous-Nuclear Ribonucleoprotein K
|
Concept
|
Mitogen-Activated Protein Kinase 9
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
Janus Kinase 2
|
Concept
|
Tryptases
|
Concept
|
RNA, Small Interfering
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
Concept
|
fms-Like Tyrosine Kinase 3
|
Concept
|
Composite Lymphoma
|
Concept
|
Autopsy
|
Concept
|
Blood Cell Count
|
Concept
|
Chlorambucil
|
Concept
|
Chromatin
|
Concept
|
Chromosomes, Human, Pair 16
|
Concept
|
Cytosine
|
Concept
|
Hedgehogs
|
Concept
|
Hemoglobinuria, Paroxysmal
|
Concept
|
Histiocytes
|
Concept
|
Immunoglobulin kappa-Chains
|
Concept
|
Leukemia, Hairy Cell
|
Concept
|
Lymphocytes
|
Concept
|
Lymphoma, Non-Hodgkin
|
Concept
|
Monocytes
|
Concept
|
Mucous Membrane
|
Concept
|
Phenotype
|
Concept
|
Predictive Value of Tests
|
Concept
|
Prospective Studies
|
Concept
|
Mast-Cell Sarcoma
|
Concept
|
Serine Endopeptidases
|
Concept
|
Splenic Neoplasms
|
Concept
|
Staining and Labeling
|
Concept
|
T-Lymphocytes
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
Concept
|
DNA Primers
|
Concept
|
fas Receptor
|
Concept
|
Point-of-Care Systems
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
Concept
|
Myeloid Cells
|
Concept
|
MicroRNAs
|
Concept
|
Cyclin-Dependent Kinase 9
|
Concept
|
Myelodysplastic-Myeloproliferative Diseases
|
Concept
|
Young Adult
|
Academic Article
|
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
|
Academic Article
|
Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
|
Academic Article
|
Myeloid leukemia after hematotoxins.
|
Academic Article
|
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
|
Academic Article
|
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
|
Academic Article
|
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
|
Academic Article
|
Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive.
|
Academic Article
|
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.
|
Academic Article
|
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
|
Academic Article
|
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
|
Academic Article
|
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
|
Academic Article
|
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
|
Academic Article
|
The World Health Organization (WHO) classification of the myeloid neoplasms.
|
Academic Article
|
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
|
Academic Article
|
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
|
Academic Article
|
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
|
Academic Article
|
Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia.
|
Academic Article
|
Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia.
|
Academic Article
|
Myelodysplastic/myeloproliferative diseases.
|
Academic Article
|
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.
|
Academic Article
|
Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity.
|
Academic Article
|
Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia.
|
Academic Article
|
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).
|
Academic Article
|
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
Academic Article
|
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
|
Academic Article
|
Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia.
|
Academic Article
|
Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe.
|
Academic Article
|
Acute myeloid leukemia with expanded erythropoiesis.
|
Academic Article
|
Chronic myelogenous leukemia, BCR-ABL1+.
|
Academic Article
|
Myelodysplastic syndromes.
|
Academic Article
|
Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations.
|
Academic Article
|
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
|
Academic Article
|
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.
|
Academic Article
|
Nonlymphoblastic T-cell lymphoma in children.
|
Academic Article
|
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia.
|
Academic Article
|
Treatment of hairy cell leukemia with recombinant alpha 2 interferon.
|
Academic Article
|
Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL.
|
Academic Article
|
MPN-associated myelofibrosis (MPN-MF).
|
Academic Article
|
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22).
|
Academic Article
|
Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.
|
Academic Article
|
Extramedullary hematopoiesis.
|
Academic Article
|
Autopsy findings in hairy cell leukemia.
|
Academic Article
|
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia.
|
Academic Article
|
Histiocytic lymphoma: response to chemotherapy.
|
Academic Article
|
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
|
Academic Article
|
A 14;19 translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosome aberration.
|
Academic Article
|
The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia.
|
Academic Article
|
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
|
Academic Article
|
Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis.
|
Academic Article
|
Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia.
|
Academic Article
|
The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982).
|
Academic Article
|
Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype.
|
Academic Article
|
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia.
|
Academic Article
|
Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia.
|
Academic Article
|
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression.
|
Academic Article
|
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
|
Academic Article
|
Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.
|
Academic Article
|
Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies.
|
Academic Article
|
Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation.
|
Academic Article
|
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
|
Academic Article
|
Ultrastructural characterization of de novo and secondary leukemias.
|
Academic Article
|
Karyotypic patterns and their clinical significance in polycythemia vera.
|
Academic Article
|
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease.
|
Academic Article
|
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
|
Academic Article
|
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
|
Academic Article
|
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
|
Academic Article
|
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
|
Academic Article
|
The classification of MDS: from FAB to WHO and beyond.
|
Academic Article
|
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia.
|
Academic Article
|
Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment.
|
Academic Article
|
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist?
|
Academic Article
|
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia.
|
Academic Article
|
Sinus histiocytosis with massive lymphadenopathy: response to cyclophosphamide therapy.
|
Academic Article
|
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies.
|
Academic Article
|
Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia.
|
Academic Article
|
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21).
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
Academic Article
|
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
|
Academic Article
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
Academic Article
|
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
Academic Article
|
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
|
Academic Article
|
Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977).
|
Academic Article
|
Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics.
|
Academic Article
|
Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma.
|
Academic Article
|
"Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity.
|
Academic Article
|
Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia?
|
Academic Article
|
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome.
|
Academic Article
|
A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease.
|
Academic Article
|
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
|
Academic Article
|
PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-a rearrangement.
|
Academic Article
|
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.
|
Academic Article
|
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
|
Concept
|
Imatinib Mesylate
|
Concept
|
Rituximab
|
Concept
|
Transcriptional Regulator ERG
|
Concept
|
RUNX1 Translocation Partner 1 Protein
|
Concept
|
Promyelocytic Leukemia Zinc Finger Protein
|